Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Taltz 80 mg, solution injectable en seringue préremplie
Drug
Taltz, solution injectable en seringue préremplie
Plaque-Psoriasis bei Erwachsenen, Psoriasis-Arthritis, Plaque-Psoriasis bei Kindern und Jugendlichen ab 6 Jahren mit einem Körpergewicht von mindestens 25 kg, Ankylosierende Spondylitis, Nicht-radiographische axiale Spondyloarthritis
07.15.0. – immunosuppressants
HAM – Human medicine
INLFS – Solution for injection in pre-filled syringe
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/12/2016
12/31/9999
Dosage strength
Taltz 80 mg, solution injectable en seringue préremplie
Psoriasis en plaques chez l'adulte, Arthrite psoriasique, Psoriasis en plaques chez l'enfant et l'adolescent à partir de 6 ans et d'un poids corporel d'au moins 25 kg, Spondylarthrite ankylosante, Spondyloarthrite axiale non radiographique
01
Z – approved
Package
No information made available
NA – No longer authorised
004
D – no longer approved
Declaration
Component
80 mg ixekizumabum
saccharum
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
Authorisation holder
7601001261853
Eli Lilly (Suisse) SA
chemin des Coquelicots 16
580
1214 Vernier (GE)
chemin des Coquelicots 16
580
1214 Vernier (GE)
Date of revision of the text
4/3/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.